Inhibikase Therapeutics Secures $110M for Drug Development

By Yahoo! Finance | Oct 11, 2024 at 06:11 PM EST

Inhibikase Therapeutics, Inc. secured a $110 million private placement deal with investors for over 58 million common stock shares, pre-funded, and Series Warrants to support advancing IkT-001Pro drug trials for pulmonary arterial hypertension.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.